FDA Inspection 822470 — Central Jersey Blood Center

Central Jersey Blood Center — FEI 1000122276

The FDA completed an inspection of Central Jersey Blood Center on Mar 1, 2013 in Howell, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 1, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Howell, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.